Additionally, long-term insulin therapy in T1D, due to autoimmune destruction of pancreatic β-cells, may lead to elevated insulin concentrations in the circulation and potential mutagenic effects of insulin analogs, increasing the risk of certain cancers46. This evidence concerns the gene INS and type 1 diabetes mellitus.